NAVIGATION DRUG Trademark

Trademark Overview


On Monday, December 21, 2020, a trademark application was filed for NAVIGATION DRUG with the United States Patent and Trademark Office. The USPTO has given the NAVIGATION DRUG trademark a serial number of 79309391. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, July 12, 2021. This trademark is owned by Goryo Chemical, Inc.. The NAVIGATION DRUG trademark is filed in the Chemical Products, Pharmaceutical Products, and Medical & Beauty Services & Agricultural Services categories with the following description:

Reagents for research purposes; reagents for chemical analyses; reagents for use in scientific apparatus for chemical or biological analysis; diagnostic reagents for scientific or research use; diagnostic reagents and preparations, except for medical or veterinary use; chemicals

Pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of diseases or disability; pharmaceutical preparations and substances used for detecting body fluids; pharmaceutical preparations and substances used for detecting pancreatic fluids; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of cancer; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of digestive system disorders; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of bone diseases; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of hyperlipidemia diseases; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of gastrointestinal diseases; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of hypoglycemia; pharmaceutical preparati...

Medical testing services using fluorescent reagents; medical laboratory services for the analysis, diagnosis, and treatment of patients using fluorescent reagents; medical analysis for the diagnosis and treatment of persons; medical diagnostic services; medical evaluation services; medical diagnostic services using fluorescent reagents; medical evaluation services using fluorescent reagents; diagnosis of diseases; diagnosis of diseases using fluorescent reagents; diagnosis of cancer; diagnosis of cancer using fluorescent reagents; medical testing services relating to the diagnosis and treatment of disease; medical testing services relating to the diagnosis and treatment of disease using fluorescent reagents; medical laboratory services relating to the diagnosis and treatment of disease using fluorescent reagents; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis for the diagnosis of cancer; cancer screening services; canc...

General Information


Serial Number79309391
Word MarkNAVIGATION DRUG
Filing DateMonday, December 21, 2020
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, July 12, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE
Attorney NameNOT AVAILABLE
Law Office Location CodeM20
Employee NameFALK, JONATHAN ROBERT
CorrespondentTOYOSAKI Reiko
Minato-ku
Tokyo 107-0062
Japan

Trademark Statements


Goods and ServicesReagents for research purposes; reagents for chemical analyses; reagents for use in scientific apparatus for chemical or biological analysis; diagnostic reagents for scientific or research use; diagnostic reagents and preparations, except for medical or veterinary use; chemicals
Goods and ServicesPharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of diseases or disability; pharmaceutical preparations and substances used for detecting body fluids; pharmaceutical preparations and substances used for detecting pancreatic fluids; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of cancer; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of digestive system disorders; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of bone diseases; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of hyperlipidemia diseases; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of gastrointestinal diseases; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of hypoglycemia; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of sarcoma; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of immune system diseases and disorders; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of hypertension; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of respiratory diseases and disorders; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of skin disorders; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of multiple sclerosis; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of cardiovascular diseases; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for treating central nervous system disorders; diagnostic biomarker reagents for medical purposes; veterinary diagnostic reagents; fluorescent diagnostic reagents for veterinary purposes; fluorescent diagnostic test reagents for veterinary purposes; diagnostic test reagents for medical purposes; fluorescent diagnostic test reagents for medical purposes; fluorescent diagnostic reagents for medical purposes; pharmaceutical preparations and other preparations for destroying vermin, fungicides, herbicides; fluorescent medical diagnostic reagents; chemical reagents for veterinary purposes; fluorescent chemical reagents for veterinary purposes; chemical reagents for medical purposes; fluorescent chemical reagents for medical purposes; reagents for medical purposes; fluorescent reagents for medical purposes; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic reagents and analysis samples for testing of body fluids; medical fluorescent diagnostic reagents and assays for testing of body fluids; medical fluorescent diagnostic reagents and analysis samples for testing of body fluids; clinical diagnostic reagents; fluorescent reagents for the clinical diagnosis; therapeutic drugs and agents
Goods and ServicesMedical testing services using fluorescent reagents; medical laboratory services for the analysis, diagnosis, and treatment of patients using fluorescent reagents; medical analysis for the diagnosis and treatment of persons; medical diagnostic services; medical evaluation services; medical diagnostic services using fluorescent reagents; medical evaluation services using fluorescent reagents; diagnosis of diseases; diagnosis of diseases using fluorescent reagents; diagnosis of cancer; diagnosis of cancer using fluorescent reagents; medical testing services relating to the diagnosis and treatment of disease; medical testing services relating to the diagnosis and treatment of disease using fluorescent reagents; medical laboratory services relating to the diagnosis and treatment of disease using fluorescent reagents; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis for the diagnosis of cancer; cancer screening services; cancer screening services using fluorescent reagents; medical laboratory services for the analysis of samples taken from patients; fluorescence imaging examination for the medical diagnosis or treatment; providing information in the field of cancer prevention, screening, diagnosis and treatment; providing medical information; providing medical information on diagnosis using fluorescent reagents; providing information on medical diagnosis using fluorescent reagents; medical analysis for the diagnosis of cancer using fluorescent reagents; rental of medical apparatus and installations; rental of medical diagnostic apparatus and installations; rental of medical diagnostic apparatus using fluorescent reagents and medical apparatus and installations using fluorescent reagents

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, April 23, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 23, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 23, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGoryo Chemical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Sunday, August 1, 2021REFUSAL PROCESSED BY IB
Monday, July 12, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, July 12, 2021REFUSAL PROCESSED BY MPU
Saturday, July 3, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, June 25, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, June 24, 2021NON-FINAL ACTION WRITTEN
Wednesday, June 16, 2021ASSIGNED TO EXAMINER
Tuesday, April 27, 2021APPLICATION FILING RECEIPT MAILED
Friday, April 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 22, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB